| Title |
Outcomes of COVID-19 in Patients With Lung Cancer Treated in a Tertiary Hospital in Madrid
|
|---|---|
| Published in |
Frontiers in oncology, September 2020
|
| DOI | 10.3389/fonc.2020.01777 |
| Pubmed ID | |
| Authors |
Antonio Calles, María Inmaculada Aparicio, Manuel Alva, Marianela Bringas, Natalia Gutierrez, Javier Soto, Marta Arregui, Victoria Clara Tirado, Enrique Luis Álvarez, María del Monte-Millán, Tatiana Massarrah, Mar Galera, Rosa Álvarez, Miguel Martín |
X Demographics
The data shown below were collected from the profiles of 56 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 14 | 25% |
| United States | 5 | 9% |
| Switzerland | 3 | 5% |
| Canada | 2 | 4% |
| United Kingdom | 1 | 2% |
| Comoros | 1 | 2% |
| Indonesia | 1 | 2% |
| Italy | 1 | 2% |
| Unknown | 28 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 41 | 73% |
| Practitioners (doctors, other healthcare professionals) | 7 | 13% |
| Scientists | 7 | 13% |
| Science communicators (journalists, bloggers, editors) | 1 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 147 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 147 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 21 | 14% |
| Student > Bachelor | 21 | 14% |
| Other | 14 | 10% |
| Researcher | 10 | 7% |
| Student > Ph. D. Student | 10 | 7% |
| Other | 17 | 12% |
| Unknown | 54 | 37% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 44 | 30% |
| Nursing and Health Professions | 11 | 7% |
| Biochemistry, Genetics and Molecular Biology | 5 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 3% |
| Immunology and Microbiology | 3 | 2% |
| Other | 15 | 10% |
| Unknown | 64 | 44% |
Attention Score in Context
This research output has an Altmetric Attention Score of 45. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 April 2021.
All research outputs
#932,267
of 25,387,668 outputs
Outputs from Frontiers in oncology
#153
of 22,433 outputs
Outputs of similar age
#26,083
of 414,888 outputs
Outputs of similar age from Frontiers in oncology
#7
of 671 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,433 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 414,888 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 671 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.